Posting Summary: An immediate postdoctoral Research Associate position is available in the Tushir-Singh Laboratory of Novel Biologics at the University of Virginia, Department of Biochemistry and Molecular Genetics, to study Antibody therapeutics in Cancer. Our research is highly translational and is focused on generating "moon shot" efforts to find the cure for cancer. More details can be found at https://med.virginia.edu/faculty/faculty-listing/js2yr/.
Our laboratory has broad interest in Bi-specific Antibodies, Receptor-Target Biology, Antibody engineering, Antibody-siRNA-conjugates and Cancer biology. We use DNA engineering based approaches supported by functional testing to evaluate and develop better technologies directed toward bispecific antibody platforms and Antibody-RNA conjugates in the cancer immunotherapy space.
To support our current ongoing activities, we are looking for a postdoctoral scientist with experience in protein engineering, optimization and characterization. Experience with flow cytometry is a must to be considered. From the model system perspective, we will prefer a candidate with strong background in basic immunology, T-cell biology, relevant immunological assays, PBMCs handling. In addition experience with siRNA design, cell culture, HPLC, animal handing and tumor xenografts is highly desirable. UVA offers an exciting working environment, the possibility to interact with interdisciplinary research groups, and HIGHLY competitive salary and benefits.
KEY RESPONSIBILITIES: 1) Participate in planning, designing and executing technical and complex research projects, as assigned under the direction of a supervisor 2) Background in molecular biology, biochemical assays, protein handling 3) Growth and maintenance of mammalian cell cultures 4) Contribute to grant application and publications 5) Proven ability to work in a collaborative research team
REQUIREMENTS/MINIMUM QUALIFICATIONS: 1) MD and/or PhD in molecular biology, Immunology, cell biology or relevant scientific discipline by appointment start date 2) Experience in Cancer cell biology and general cell signaling 3) Excellent communication skills
PREFERRED QUALIFICATIONS 1) Experience with T-cells and other immunological techniques 2) Experience with Flow Cytometry, HPLC, and animal handling is highly desirable 3) Expertise in basic protein purification and optimization techniques.
Interested candidates should apply at https://jobs.virginia.edu and search on Posting 0619681. Fill out a candidate profile and submit a CV; a description of research interests, technical skills, past projects and publications; and contact information for three references. This position in contingent upon the continued availability of funding.
For additional information regarding the application process, please contact Helen Norfleet-Shiflett, via email firstname.lastname@example.org or telephone (434) 924-1667.
The University of Virginia is an equal opportunity and affirmative action employer. Women, minorities, veterans, and persons with disabilities are encouraged to apply.
Founded by Thomas Jefferson, the University of Virginia opened in 1825 as the nation's first public university. A longstanding dedication to preeminence in both scholarship and teaching; top ranking in global satisfaction, collegiality and work/family issues on the COACHE survey of early career faculty; a commitment to excellence that is integrally connected with diversity and a broad array of ben...efits make the University of Virginia a prime choice for both faculty and staff. The University of Virginia is located in the small cosmopolitan city of Charlottesville near the Blue Ridge Mountains, 70 miles from Richmond and 110 miles from Washington, D.C. The University of Virginia remains the No. 2 best public university in the 2013 edition of the U.S. News and World Report rankings. In the 14 years since U.S. News began ranking public universities as a separate category, U.Va. has ranked either No. 1 or No. 2. U.Va. continues to rank in the Top 25 among the best of all national universities, public and private.